Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NextTrip, Inc. Director's Dealing 2021

Aug 14, 2021

34837_dirs_2021-08-13_66b2500b-8181-4f2a-a3e3-4f0179c4e9b1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SIGMA LABS, INC. (SGLB)
CIK: 0000788611
Period of Report: 2021-08-11

Reporting Person: Orzechowski Frank (CFO, PFO and PAO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-08-11 Stock Option (right to buy) $3.42 A 48580 Acquired 2026-08-11 Common Stock (48580) Direct
2021-08-11 Stock Appreciation Right $3.42 A 48580 Acquired 2026-08-11 Common Stock (48580) Direct

Footnotes

F1: The stock option will vest and become exercisable as follows: (i) 25% of the option vested on the grant date (i.e., August 11, 2021), and (ii) the balance of the option will vest in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.

F2: The stock appreciation right ("SAR") is payable in cash only, and vests as follows: (i) 25% of the SAR vested on the grant date (i.e., August 11, 2021), and (ii) the balance of the SAR will vest in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.